Research

Funding Opportunities

At the RTICC, We are committed to fostering groundbreaking cancer research by offering various funding opportunities to support both senior researchers and emerging scientists.

We invite Principal Investigators (PIs), students, and post-doctoral fellows to explore our available funding to advance cancer research, innovation, and collaboration.

Funding Opportunities for Principal Investigators (PIs)

RTICC International Invited Guest Speakers

RTICC Call for Proposals for International Invited Guest Speakers

The RTICC invites its members to nominate outstanding international researchers as guest speakers in March-December 2026.

Eligible guests are internationally renowned researchers at the level of Associate Professor or Full Professor, recognized experts in their fields, with a strong connection to cancer research.

Submission Deadline: December 15th, 2025

LUMENX

RTICC & MATRiC Cancer 3D Bioprinting Call for Proposals

In collaboration with ‘MATRiC - Applied Medical Technology Research Center’ (Division of Research, Rambam Health Care Campus), the RTICC is launching a call for proposals to fund projects of cancer 3D bioprinting by RTICC researchers.

Proposals that leverage this technology to advance cancer biology, drug screening, and preclinical testing are welcome.
Three applications in the sum of 20,000$ will be selected for funding.

Submission Deadline: Call for Proposals for 2025 has ended.

Funding Opportunities for Students and Post-Docs

The 51st class of the Rappaport Faculty of Medicine

RTICC Collaborative Grants for Multidisciplinary Cancer Research

The Bruce and Ruth Rappaport Cancer Research Center (RTICC) connects basic cancer research and clinical/ translational oncology, with exact sciences and engineering under one umbrella. We aim to advance multidisciplinary cancer research, bridging between RTICC laboratories at the Technion to support the next generation of scientists and physicians.
The RTICC offers collaborative grants for dually-mentored young investigators (PhD students, postdoctoral fellows, and physicians) for multidisciplinary cancer research.

Submission Deadline: Call for Proposals for 2025 has ended.